K. Weinger et Am. Jacobson, COGNITIVE IMPAIRMENT IN PATIENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS - INCIDENCE, MECHANISMS AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(3), 1998, pp. 233-252
Patients with type 1 (insulin-dependent) diabetes mellitus can experie
nce both very low and very high blood glucose levels that may affect t
he CNS. Over time, high glucose levels (hyperglycaemia) may result in
ketoacidosis, seizures, coma and death, Although a wide variation in r
esponse exists, acute hypoglycaemia (low blood sugar level) generally
results in a decrease in tile supply of glucose to the brain. Progress
ively lower glucose levels can result in confusion, inability to conce
ntrate or cogitate. seizures, coma or death. Much progress has been ma
de in the understanding of systemic and brain glucose metabolism, and
the metabolic changes that are associated with type diabetes mellitus.
Research during the last 2 decades has clarified specific cognitive f
unction and cognitive deficits during glucose fluctuations, particular
ly hypoglycaemia. In addition, recent research efforts have attempted
to differentiate between the acute and chronic influences of glycaemic
level on brain physiology and function, and tu determine if glucose f
luctuations lead to permanent intellectual impairment. Additional stud
ies have examined the mechanisms underlying the potentiating effect of
alcohol (ethanol) on insulin-induced hypoglycaemia. Finally, clinical
interventions have been developed that are directed at the prevention
and early treatment of hypoglycaemia through cartful management of in
sulin dose and timing and through extensive patient and family educati
on.